Skip to contentP
Petmed Express Inc
P
PETSPetmed Express Inc Q4 2019 · 10-K
Revenue$64.57M$64.57M−4.1% vs Q4 2018 Net Income$6.62M$6.62M−35.0% vs Q4 2018 EPS Diluted$0.32$0.32−36.0% vs Q4 2018 Gross Profit$20,724,000−16.8% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Petmed Express Inc · CIK 1040130 · Engraved from SEC EDGAR
Operating Cash Flowderived$13,113,000+487.0% Free Cash Flowderived$13,000,000+520.5% Margins · derivedGross margin32.1%−4.9 pt vs Q4 2018
Operating margin12.1%−8.7 pt vs Q4 2018
Net margin10.3%−4.9 pt vs Q4 2018
ended Mar 31, 2019 · filed May 28, 2019 · 58 d after period end